We frequently update our articles to reflect the latest changes and updates to Medicare, and strongly recommend you visit this article at link below to confirm you have the latest version.
Printed Date: 9/22/2015
The Molecular Diagnostic Services Program (MolDX) was developed to identify and establish coverage and reimbursement for molecular diagnostic tests. MolDX success hinges on three components: Test registration and ID assignment, application review, and coverage determination and reimbursement.
We value your opinion and want to provide the highest-quality and most relevant Medicare knowledge possible. Please let us know if this article was helpful.
It didn't answer my question
This article was helpful
We’re glad we could help you today and appreciate your feedback. When you rate our articles as most helpful, we know that we are on the right track for providing you with important news and information.
We're sorry this article didn't help you today. We'll use your feedback to review this article try to revise or expand it. In the meantime we recommend you:
Last Updated: 5/01/2021
Applies to: MolDx
Article Topics: Appeals, Redeterminations, and PTANs
We've recently uppgraded our website and it looks you're trying to access an old link. Please select an option below.
Go to Home page
View a related article: